The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Signal Transduction Inhibitors-Global Market Insights and Sales Trends 2024

Signal Transduction Inhibitors-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1861851

No of Pages : 95

Synopsis
Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.
The global Signal Transduction Inhibitors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Signal Transduction Inhibitors in various end use industries. The expanding demands from the Hospital Pharmacies and Retail Pharmacies, are propelling Signal Transduction Inhibitors market. Dasatinib, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erlotinib segment is estimated at % CAGR for the next seven-year period.
Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Signal Transduction Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Signal Transduction Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Signal Transduction Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Signal Transduction Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Signal Transduction Inhibitors covered in this report include Bristol-Myers Squibb, Roche, AstraZeneca, GSK, Novartis, Amgen and Pfizer, etc.
The global Signal Transduction Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Roche
AstraZeneca
GSK
Novartis
Amgen
Pfizer
Global Signal Transduction Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Signal Transduction Inhibitors market, Segment by Type:
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib
Global Signal Transduction Inhibitors market, by Application
Hospital Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Signal Transduction Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Signal Transduction Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Signal Transduction Inhibitors Market Overview
1.1 Signal Transduction Inhibitors Product Overview
1.2 Signal Transduction Inhibitors Market Segment by Type
1.2.1 Dasatinib
1.2.2 Erlotinib
1.2.3 Gefitinib
1.2.4 Imatinib
1.2.5 Lapatinib
1.2.6 Nilotinib
1.2.7 Pazopanib
1.2.8 Sorafenib
1.2.9 Sunitinib
1.3 Global Signal Transduction Inhibitors Market Size by Type
1.3.1 Global Signal Transduction Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Signal Transduction Inhibitors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Signal Transduction Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Signal Transduction Inhibitors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Signal Transduction Inhibitors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Signal Transduction Inhibitors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Signal Transduction Inhibitors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Signal Transduction Inhibitors Sales Breakdown by Type (2018-2023)
2 Global Signal Transduction Inhibitors Market Competition by Company
2.1 Global Top Players by Signal Transduction Inhibitors Sales (2018-2023)
2.2 Global Top Players by Signal Transduction Inhibitors Revenue (2018-2023)
2.3 Global Top Players by Signal Transduction Inhibitors Price (2018-2023)
2.4 Global Top Manufacturers Signal Transduction Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Signal Transduction Inhibitors Market Competitive Situation and Trends
2.5.1 Signal Transduction Inhibitors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Signal Transduction Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Signal Transduction Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Signal Transduction Inhibitors Market
2.8 Key Manufacturers Signal Transduction Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Signal Transduction Inhibitors Status and Outlook by Region
3.1 Global Signal Transduction Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Signal Transduction Inhibitors Historic Market Size by Region
3.2.1 Global Signal Transduction Inhibitors Sales in Volume by Region (2018-2023)
3.2.2 Global Signal Transduction Inhibitors Sales in Value by Region (2018-2023)
3.2.3 Global Signal Transduction Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Signal Transduction Inhibitors Forecasted Market Size by Region
3.3.1 Global Signal Transduction Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Signal Transduction Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Signal Transduction Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Signal Transduction Inhibitors by Application
4.1 Signal Transduction Inhibitors Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.2 Global Signal Transduction Inhibitors Market Size by Application
4.2.1 Global Signal Transduction Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Signal Transduction Inhibitors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Signal Transduction Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Signal Transduction Inhibitors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Signal Transduction Inhibitors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Signal Transduction Inhibitors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Signal Transduction Inhibitors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Signal Transduction Inhibitors Sales Breakdown by Application (2018-2023)
5 North America Signal Transduction Inhibitors by Country
5.1 North America Signal Transduction Inhibitors Historic Market Size by Country
5.1.1 North America Signal Transduction Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Signal Transduction Inhibitors Sales in Volume by Country (2018-2023)
5.1.3 North America Signal Transduction Inhibitors Sales in Value by Country (2018-2023)
5.2 North America Signal Transduction Inhibitors Forecasted Market Size by Country
5.2.1 North America Signal Transduction Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Signal Transduction Inhibitors Sales in Value by Country (2024-2029)
6 Europe Signal Transduction Inhibitors by Country
6.1 Europe Signal Transduction Inhibitors Historic Market Size by Country
6.1.1 Europe Signal Transduction Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Signal Transduction Inhibitors Sales in Volume by Country (2018-2023)
6.1.3 Europe Signal Transduction Inhibitors Sales in Value by Country (2018-2023)
6.2 Europe Signal Transduction Inhibitors Forecasted Market Size by Country
6.2.1 Europe Signal Transduction Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Signal Transduction Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Signal Transduction Inhibitors by Region
7.1 Asia-Pacific Signal Transduction Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Signal Transduction Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Signal Transduction Inhibitors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Signal Transduction Inhibitors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Signal Transduction Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Signal Transduction Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Signal Transduction Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Signal Transduction Inhibitors by Country
8.1 Latin America Signal Transduction Inhibitors Historic Market Size by Country
8.1.1 Latin America Signal Transduction Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Signal Transduction Inhibitors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Signal Transduction Inhibitors Sales in Value by Country (2018-2023)
8.2 Latin America Signal Transduction Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Signal Transduction Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Signal Transduction Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Signal Transduction Inhibitors by Country
9.1 Middle East and Africa Signal Transduction Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Signal Transduction Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Signal Transduction Inhibitors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Signal Transduction Inhibitors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Signal Transduction Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Signal Transduction Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Signal Transduction Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Signal Transduction Inhibitors Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Signal Transduction Inhibitors Products Offered
10.2.5 Roche Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Signal Transduction Inhibitors Products Offered
10.3.5 AstraZeneca Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GSK Signal Transduction Inhibitors Products Offered
10.4.5 GSK Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Signal Transduction Inhibitors Products Offered
10.5.5 Novartis Recent Development
10.6 Amgen
10.6.1 Amgen Company Information
10.6.2 Amgen Introduction and Business Overview
10.6.3 Amgen Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amgen Signal Transduction Inhibitors Products Offered
10.6.5 Amgen Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Signal Transduction Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Signal Transduction Inhibitors Products Offered
10.7.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Signal Transduction Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Signal Transduction Inhibitors Industrial Chain Analysis
11.4 Signal Transduction Inhibitors Market Dynamics
11.4.1 Signal Transduction Inhibitors Industry Trends
11.4.2 Signal Transduction Inhibitors Market Drivers
11.4.3 Signal Transduction Inhibitors Market Challenges
11.4.4 Signal Transduction Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Signal Transduction Inhibitors Distributors
12.3 Signal Transduction Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’